S&P/ASX 200 (INDEXASX:XJO) retreated 0.95% to 5896 by around 12.45 pm and is on track to finish the month in the red, the first monthly decline since March 2020 when the index fell 21%.
Wall Street closed lower overnight, snapping a three-day winning streak as investors stepped back before the first US presidential debate.
Losses across the board[hhmc]
All sectors on the S&P/ASX 200 are in decline with energy falling most. The big four banks fell along with BHP Group (ASX:BHP) (-1.08%) and CSL Ltd (ASX:CSL) (-0.93%).
Global oil prices slumped more than 3% overnight as Europe and the US responded to a second wave of COVID-19 cases.
Positive manufacturing activity data from China[hhmc]
Chinas official manufacturing Purchasing Managers Index (PMI) for September came in at 51.5 as compared to 51.0 in August.
Analysts were expecting the PMI to come in at 51.2 in September. PMI readings above 50 signal expansion from the previous month, while those below 50 signal contraction.
Todays top gainers on the ASX include Euro Manganese Inc CDI (ASX:EMN) (+25.64%), Bryah Resources Ltd (ASX:BYH) (+16.07%), Havilah Resources Ltd (ASX:HAV) (+37.93%), Cellmid Limited (ASX:CDY) (+9.52%) and Pure Minerals Ltd (ASX:PM1) (+9.52%).
Proactive news headlines:
Kingston Resources receives more strong gold results from Livingstone as drilling resumes[hhmc]
Highfield Resources securing key Joy miner bolter for development of Muga Potash Project[hhmc]
GTI Resources buoyed after intersecting quartz vein structures in drilling at Niagara[hhmc]
GTI Resources Ltd (ASX:GTR) has received encouraging indications from recent aircore drilling at Niagara Gold Project in Western Australia with quartz veining intersected in a number of drill holes at predicted positions.
Emyria signs real-world data agreement with Zelira Therapeutics for insomnia drug Zenivol[hhmc]